HIV I Infection
31
6
9
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.2%
1 terminated out of 31 trials
93.8%
+7.2% vs benchmark
10%
3 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 15 completed trials
Clinical Trials (31)
Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA
Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Evaluating the Safety and Immunogenicity of MTBVAC
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset
Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France
Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF
The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV
Studying Topiramate for Re-Activating the HIV-1 Reservoir
The Visceral Adiposity Measurement and Observation Study
Acute Effects of TCIG vs ECIG in PLWH